Skip to main content

Table 4 Summary of finding about antimicrobial stewardship implementation before and during the COVID-19 pandemic

From: Antimicrobial stewardship implementation before and during the COVID-19 pandemic in the acute care settings: a systematic review

Study

  

Antimicrobial Stewardship (AMS)

AMS Strategies

AMS Core Strategies

AMS Supplemental Strategies

 

Before-the-pandemic

During-the-pandemic

Multidisciplinary stewardship team

Formulary restrictions and preauthorization

Antibiotic Review

Prospective Audit and Feedback

Streamlining/timely de-escalation of therapy

Dose Optimisation

Parenteral to oral conversion

Guidelines and Clinical Pathways

Antibiotic Order Form

Trivedi (2013) [19]

 

Kallen (2017) [20]

 

 

  

  

Tamma (2021) [21]

 

 

   

 

Surat (2021) [22]

 

 

 

 

Weston (2012) [23]

 

Mehta (2014) [24]

 

 

   

Moriyama (2021) [25]

 

 

     

Thakkar (2021) [26]

 

  

Panditrao (2021) [27]

 

 

 

 

Ababneh (2020) [28]

 

 

 

 

 

Spernovasilis (2021) [29]

 

 

 

 

 

Ashiru-Oredope (2021) [30]

 

 

 

 

Williams (2021) [31]

 

       

 

Study

Antimicrobial Stewardship (AMS)

AMS Measure

 

AMS Education

Computerized decision support, surveillance

Laboratory surveillance and feedback

Defined Daily Dose (DDD)

Days of Therapy (DOT)

Length of Stay (LOS)

Cost

Clostridioides Difficile Infection (CDI)

Procalcitonin (PCT)

Indicators or Quality Improvement Projects

Trivedi (2013) [19]

 

 

Kallen (2017) [20]

  

   

Tamma (2021) [21]

   

  

 

Surat (2021) [22]

 

   

Weston (2012) [23]

       

Mehta (2014) [24]

  

 

  

Moriyama (2021) [25]

      

   

Thakkar (2021) [26]

 

 

     

Panditrao (2021) [27]

  

    

Ababneh (2020) [28]

   

    

Spernovasilis (2021) [29]

 

       

Ashiru-Oredope (2021) [30]

      

Williams (2021) [31]

 

   

  1. DDD Defined Daily Doses, DOT Days of Therapy, CDI Clostridioides Difficile Infection, LOS Length of Stay, PCT Procalcitonin